内視鏡可視化システムの世界市場-2024～2031年

概要

内視鏡可視化システムの世界市場は、2023年に178億2,000万米ドルに達し、2031年には299億4,000万米ドルに達すると予測され、予測期間2024年にはCAGR 6.7%で成長すると予測されています。

内視鏡可視化システムは、内視鏡処置中に内臓や構造の高解像度画像を提供するように設計された先進医療機器です。これらのシステムは、カメラ、光源、モニター、ビデオプロセッサを含む様々なコンポーネントで構成され、医療プロバイダーに鮮明で詳細な視覚情報を提供するために協働します。消化器、泌尿器、婦人科、整形外科など、多くの医療セグメントで重要な役割を担っています。

これらの先進的システムは、内視鏡検査時の画質を向上させ、様々な症状の診断と治療の改善を可能にします。高精細（HD）と超高精細（UHD）技術を活用することで、これらの装置は病変やその他の異常の正確な特定を容易にします。人工知能の統合により、処置中のリアルタイム分析と支援が可能になり、その能力はさらに向上します。全体として、内視鏡可視化システムは低侵襲手術の有効性と安全性を大幅に改善する不可欠なツールです。これらの要因が内視鏡可視化システムの世界市場拡大の原動力となっています。

市場力学：

促進要因と抑制要因

低侵襲手術に対する需要の高まり

低侵襲手術に対する需要の高まりは、世界の内視鏡可視化システム市場の成長を大きく牽引しており、市場予測期間中も牽引していくと予測されています。

低侵襲手術（MIS）への嗜好の高まりは、内視鏡可視化システム市場の重要な促進要因です。この動向は、主に低侵襲技術に関連する数多くの利点に起因しており、様々な医療セグメントで外科手術に革命をもたらしています。

低侵襲手術は一般的に切開創が小さいため、身体への外傷が少ないです。その結果、患者は従来の開腹手術に比べて回復が早くなることが多いです。多くの人は数週間ではなく数日以内に通常の活動を再開することができ、全体的な患者の満足度を高め、より多くの人がこのような手術を選択するようになります。

切開創が小さいため、一般的に術後の痛みや不快感が少ないです。低侵襲手術を受けた患者は、痛みのレベルが著しく低いことを頻繁に報告し、強い麻薬の代わりに市販薬で対処できることが多いです。このような痛みの軽減は、患者の体験を改善するだけでなく、オピオイド使用に伴うリスクを最小限に抑えます。

さらに、この世界内視鏡可視化システム市場成長の原動力となるような製品の発売や承認が、産業の主要企業によって行われています。例えば、2022年9月、Olympus Corporationは、さまざまな医療セグメントで内視鏡手術を行う医療従事者（HCP）の多様なニーズを満たすように設計された最新の手術可視化プラットフォームであるVISERA ELITE IIIの発売を発表しました。この先進的なシステムは、複数の画像処理機能を1つのプラットフォームに統合することで手術能力を向上させ、腹腔鏡下大腸切除術や腹腔鏡下胆嚢摘出術などの低侵襲治療を容易にすることを目的としています。

また、2024年2月には、ビデオ内視鏡「i20c」シリーズの新機種「PENTAX Medical Video Colonoscope EC34-i20c」、「PENTAX Medical Video Upper GI Scope EG27-i20c」、「R/LノブアダプターOE-B17」がCEマークを取得しました。これらの進歩は、内視鏡処置中の発見、診断、治療における医療専門家の能力を高めることを目的としています。これらすべての要因が、世界の内視鏡可視化システム市場に需要をもたらしています。

さらに、技術的進歩に対する需要の高まりが、内視鏡可視化システムの世界市場拡大に寄与しています。

設備コストの高さ

設備コストが高いことが、内視鏡可視化システムの世界市場の成長を阻害します。先進的な内視鏡可視化システムに必要な多額の投資は高額です。これらのシステムの購入、設置、継続的なメンテナンスに関連する高額な費用は、特に財源が限られている発展途上地域の医療施設の意欲を削ぐ可能性があります。この経済的障壁が新技術の採用を制限し、内視鏡可視化システムの世界市場全体の成長を妨げる可能性があります。

内視鏡可視化システムの価格構造は、技術的進歩、ブランド価値、市場需要のバランスを反映しています。2024年のLabX Media Groupによると、新品のシステムは2万ドルから15万ドル、中古のオプションは5,000ドルから7万5,000ドルとなっており、医療施設は診断や手術の能力を高めつつも、さまざまな資金力に合わせたさまざまな選択肢を持つことができます。このような価格設定の柔軟性は、多様な医療環境において先進医療技術へのアクセスを拡大する上で極めて重要です。したがって、上記の要因は、世界の内視鏡可視化システム市場の潜在的成長を制限している可能性があります。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 影響要因
  • 促進要因
    • 低侵襲手術の需要増加
  • 抑制要因
    • 設備の高コスト
  • 機会
  • 影響分析

第5章 産業分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• 価格分析
• 規制分析

第6章 製品タイプ別

• 内視鏡可視化システム
  • ハイエンド可視化システム
  • ミドルエンド可視化システム
  • ローエンド可視化システム
• 内視鏡可視化コンポーネント
  • カメラヘッド
  • モニター
  • 光源
  • 吸入器
  • ビデオプロセッサ
  • プリンター

第7章 解像度タイプ別

• 4K
• フルHD

第8章 用途別

• 消化器内科
• 婦人科
• 泌尿器科
• 整形外科
• 心臓病学
• その他

第9章 エンドユーザー別

• 病院と専門クリニック
• 画像診断センター
• その他

第10章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • スペイン
  • イタリア
  • その他の欧州
• 南米
  • ブラジル
  • アルゼンチン
  • その他の南米
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他のアジア太平洋
• 中東・アフリカ

第11章 競合情勢

• 競合シナリオ
• 市況・シェア分析
• M&A分析

第12章 企業プロファイル

• Olympus
• Boston Scientific Corporation
• Medtronic
• KARL STORZ
• Stryker Corporation
• Fujifilm Corporation
• CONMED Corporation
• Pentax Medical（Hoya Group）
• Richard Wolf GmbH
• Smith+Nephew

第13章 付録

Overview

The global endoscopy visualization systems market reached US$ 17.82 billion in 2023 and is expected to reach US$ 29.94 billion by 2031, growing at a CAGR of 6.7 % during the forecast period 2024-2031.

Endoscopy visualization systems are advanced medical instruments designed to deliver high-resolution images of internal organs and structures during endoscopic procedures. These systems comprise various components, including cameras, light sources, monitors, and video processors, which collaborate to provide healthcare providers with clear and detailed visual information. They are crucial in numerous medical fields, such as gastrointestinal, urology, gynecology, and orthopedics.

These advanced systems enhance the imaging quality during endoscopic examinations, allowing for improved diagnosis and treatment of various conditions. By utilizing high-definition (HD) and ultra-high-definition (UHD) technologies, these devices facilitate the accurate identification of lesions and other abnormalities. The integration of artificial intelligence further boosts their capabilities by enabling real-time analysis and assistance during procedures. Overall, endoscopy visualization systems are essential tools that significantly improve the effectiveness and safety of minimally invasive surgeries. These factors have driven the global endoscopy visualization systems market expansion.

Market Dynamics: Drivers & Restraints

Rising Demand for Minimally Invasive Procedures

The rising demand for minimally invasive procedures is significantly driving the growth of the global endoscopy visualization systems market and is expected to drive throughout the market forecast period.

The increasing preference for minimally invasive surgeries (MIS) is a crucial driver in the endoscopy visualization systems market. This trend is primarily attributed to the numerous advantages associated with minimally invasive techniques, which are revolutionizing surgical practices across various medical fields.

Minimally invasive procedures typically involve smaller incisions, leading to less trauma to the body. As a result, patients often experience quicker recovery times compared to traditional open surgeries. Many individuals can resume their normal activities within days rather than weeks, enhancing overall patient satisfaction and encouraging more people to choose these procedures.

Smaller incisions generally result in less postoperative pain and discomfort. Patients undergoing minimally invasive surgeries frequently report significantly lower pain levels, which can often be managed with over-the-counter medications instead of stronger narcotics. This reduction in pain not only improves the patient experience but also minimizes the risks associated with opioid use.

Furthermore, key players in the industry product launches and approvals that would drive this global endoscopy visualization systems market growth. For instance, in September 2022, Olympus Corporation announced the launch of the VISERA ELITE III, its latest surgical visualization platform designed to meet the diverse needs of healthcare professionals (HCPs) performing endoscopic procedures across various medical disciplines. This advanced system aims to enhance surgical capabilities by integrating multiple imaging functions into a single platform, facilitating minimally invasive therapies such as Laparoscopic Colectomy and Laparoscopic Cholecystectomy.

Also, in February 2024, PENTAX Medical received CE marks for its new models in the i20c Video Endoscope Series, which includes the PENTAX Medical Video Colonoscope EC34-i20c, PENTAX Medical Video Upper GI Scope EG27-i20c, and the R/L Knob Adaptor OE-B17. These advancements aim to enhance the capabilities of healthcare professionals in detection, diagnosis, and therapy during endoscopic procedures. All these factors demand the global endoscopy visualization systems market.

Moreover, the rising demand for technological advancements contributes to the global endoscopy visualization systems market expansion.

High Costs of Equipment

The high costs of equipment will hinder the growth of the global endoscopy visualization systems market. The significant investment needed for advanced endoscopy visualization systems is expensive. The high expenses related to the purchase, installation, and ongoing maintenance of these systems can discourage healthcare facilities, especially in developing regions where financial resources are more constrained. This economic barrier restricts the adoption of new technologies and may hinder overall global endoscopy visualization systems market growth.

The pricing structure for endoscopy visualization systems reflects a balance between technological advancements, brand value, and market demand. As per LabX Media Group in 2024, with new systems ranging from $20,000 to $150,000 and used options available from $5,000 to $75,000, healthcare facilities have various choices that can fit different financial capacities while still enhancing their diagnostic and surgical capabilities. This flexibility in pricing is crucial for expanding access to advanced medical technologies across diverse healthcare settings. Thus, the above factors could be limiting the global endoscopy visualization systems market's potential growth.

Segment Analysis

The global endoscopy visualization systems market is segmented based on product type, resolution type, application, end-user, and region.

Product Type:

The endoscopy visualization systems segment is expected to dominate the global endoscopy visualization systems market share.

The endoscopy visualization systems segment holds a major portion of the global endoscopy visualization systems market share and is expected to continue to hold a significant portion of the global endoscopy visualization systems market share during the forecast period.

The endoscopy visualization systems segment within the larger endoscopy visualization systems market is a crucial area focusing on advanced technologies that enhance the visualization of internal structures during endoscopic procedures. This segment is essential for improving diagnostic accuracy and treatment outcomes across various medical fields.

Endoscopy visualization systems are sophisticated video systems designed to deliver high-definition images and videos during endoscopic surgeries. These systems significantly improve imaging quality, enabling healthcare professionals to visualize internal anatomy with greater clarity and precision.

The endoscopy visualization systems typically consist of several key components including cameras, monitors, light sources, video processors, and printers. The segment can be categorized based on the level of technology and features offered High-End visualization systems, mid-range, and low-end systems. These options offer basic imaging capabilities suitable for less complex procedures, making them more accessible to a broader range of healthcare facilities.

Furthermore, key players' strategies such as partnerships & collaborations, and product launches would drive this segment growth in the global endoscopy visualization systems market. For instance, in September 2022, Endoluxe announced a significant development agreement with Synodic aimed at enhancing its advanced technology capabilities in the medical field, particularly in endoscopic visualization. This partnership is set to leverage Synopic's expertise in image sensing, machine learning, and visualization technologies to create an innovative Endoluxe Visualization System (EVS), which promises to revolutionize how endoscopic procedures are conducted.

Also, in November 2021, Fujifilm launched the ColoAssist PRO, a real-time endoscope visualization system designed to assist endoscopists during colonoscopies. This system is part of Fujifilm's ELUXEO Ultra family of technologies and aims to enhance the efficiency and accuracy of colonoscopic procedures. The ColoAssist PRO allows clinicians to visualize the configuration of the endoscope throughout the procedure. This feature is crucial for helping healthcare professionals maneuver the colonoscope accurately within the patient's colon, which can be complex due to the organ's anatomy. These factors have solidified the segment's position in the global endoscopy visualization systems market.

Geographical Analysis

North America is expected to hold a significant position in the global endoscopy visualization systems market share

North America holds a substantial position in the global endoscopy visualization systems market and is expected to hold most of the market share.

The increasing occurrence of chronic diseases, including gastrointestinal disorders, cancer, and obesity, is a significant concern in North America. For instance, according to the American Cancer Society projected that in January 2024, there would be approximately 106,590 new cases of colon cancer expected to be diagnosed, with 54,210 cases in men and 52,380 cases in women.

Additionally, there will be about 46,220 new cases of rectal cancer, comprising 27,330 cases in men and 18,890 cases in women. This escalating disease burden creates a heightened demand for effective diagnostic and treatment options, particularly advanced endoscopy visualization systems.

There is a rising preference for minimally invasive surgical techniques due to their numerous benefits, such as shorter recovery times, reduced pain levels, and lower risks of complications. Endoscopy visualization systems are crucial for these types of procedures, as they enable surgeons to perform intricate operations with enhanced precision and less trauma to patients.

Ongoing advancements in imaging technology have significantly improved the quality of endoscopic images. High-definition (HD) and ultra-high-definition (UHD) systems provide clearer visuals, while innovations like artificial intelligence (AI) integration for real-time lesion detection further enhance diagnostic capabilities. These technological improvements make endoscopy visualization systems more attractive to healthcare providers.

Furthermore, in this region, a major number of key players' presence, well-advanced healthcare infrastructure, government initiatives & regulatory support, investments, and product launches & approvals would propel the global endoscopy visualization systems market.

For instance, in October 2023, Olympus Corporation announced the market launch of its next-generation EVIS X1 endoscopy system. This advanced system is designed to improve gastrointestinal (GI) diagnostics and treatment, showcasing Olympus's commitment to innovation in medical technology in Canada. Thus, the above factors are consolidating the region's position as a dominant force in the global endoscopy visualization systems market.

Asia Pacific is growing at the fastest pace in the global endoscopy visualization systems market

Asia Pacific holds the fastest pace in the global endoscopy visualization systems market and is expected to hold most of the market share.

The prevalence of chronic diseases, particularly gastrointestinal disorders, cancer, and obesity, is on the rise in the Asia-Pacific region. This increase creates a greater need for effective diagnostic and treatment options, including advanced endoscopy visualization systems. The growing patient population requiring endoscopic interventions drives demand for these technologies.

There is a notable shift towards minimally invasive surgical techniques due to their associated benefits, such as shorter recovery times, reduced pain, and lower risk of complications. Endoscopy visualization systems are essential for these procedures, enabling surgeons to perform complex operations with enhanced precision and less trauma to patients.

Continuous innovations in imaging technology, including high-definition (HD) and ultra-high-definition (UHD) systems, have significantly improved the quality of endoscopic images. The integration of artificial intelligence (AI) for real-time lesion detection further enhances diagnostic capabilities, making these systems more appealing to healthcare providers.

Furthermore, major players in the region, government initiatives, and investments, enhanced awareness among patients and physicians, increased healthcare expenditure, and product launches that would drive this endoscopy visualization systems market growth. For instance, in September 2024, Stryker announced the launch of its innovative 1788 Advanced Imaging Platform in India. This platform represents Stryker's most comprehensive and sophisticated surgical visualization system to date, designed to enhance imaging capabilities across multiple medical specialties and improve patient outcomes.

Thus, the above factors are consolidating the region's position as the fastest-growing force in the global endoscopy visualization systems market.

Competitive Landscape

The major global players in the endoscopy visualization systems market include Olympus, Boston Scientific Corporation, Medtronic, KARL STORZ, Stryker Corporation, Fujifilm Corporation, CONMED Corporation., Pentax Medical (Hoya Group), Richard Wolf GmbH., and Smith+Nephew. among others.

Emerging Players

The emerging players in the global endoscopy visualization systems market include Ambu Inc., Surgical Science, and Endoluxe among others.

Key Developments

• In September 2024, Olympus Latin America announced the launch of the EVIS X1 endoscopy system in Brazil, marking the introduction of their most advanced endoscopy technology. This system is designed to enhance the detection and treatment of gastrointestinal diseases, particularly colorectal cancer.
• In September 2024, Olympus Corporation, announced the launch of its new 4K camera head, designated CH-S700-08-LB, specifically designed for endoscopic procedures in urology and gynecology. This innovative camera head is compatible with the VISERA ELITE III video system center, which is utilized for surgical endoscopy.

Why Purchase the Report?

• Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global endoscopy visualization systems market report would provide approximately 70 tables, 63 figures, and 183 pages.

Target Audience 2023

• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Product Type
• 3.2. Snippet by Resolution Type
• 3.3. Snippet by Application
• 3.4. Snippet by End-User
• 3.5. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Rising Demand for Minimally Invasive Procedures
  • 4.1.2. Restraints
    • 4.1.2.1. High Costs of Equipment
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis

6. By Product Type

• 6.1. Introduction
  • 6.1.1. Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 6.1.2. Market Attractiveness Index, By Product Type
• 6.2. Endoscopy Visualization Systems*
  • 6.2.1. Introduction
  • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.2.3. High-End Visualization Systems
  • 6.2.4. Middle-End Visualization Systems
  • 6.2.5. Low-End Visualization Systems
• 6.3. Endoscopy Visualization Components
  • 6.3.1. Camera Heads
  • 6.3.2. Monitors
  • 6.3.3. Light Sources
  • 6.3.4. Insufflators
  • 6.3.5. Video Processors
  • 6.3.6. Printers

7. By Resolution Type

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Resolution Type
  • 7.1.2. Market Attractiveness Index, By Resolution Type
• 7.2. 4K*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. FHD

8. By Application

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 8.1.2. Market Attractiveness Index, By Application
• 8.2. Gastroenterology*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Gynecology
• 8.4. Urology
• 8.5. Orthopedic
• 8.6. Cardiology
• 8.7. Others

9. By End-User

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 9.1.2. Market Attractiveness Index, By End-User
• 9.2. Hospitals & Specialty Clinics*
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 9.3. Diagnostic Imaging Centers
• 9.4. Others

10. By Region

• 10.1. Introduction
  • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 10.1.2. Market Attractiveness Index, By Region
• 10.2. North America
  • 10.2.1. Introduction
  • 10.2.2. Key Region-Specific Dynamics
  • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Resolution Type
  • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.2.7.1. U.S.
    • 10.2.7.2. Canada
    • 10.2.7.3. Mexico
• 10.3. Europe
  • 10.3.1. Introduction
  • 10.3.2. Key Region-Specific Dynamics
  • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Resolution Type
  • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.3.7.1. Germany
    • 10.3.7.2. U.K.
    • 10.3.7.3. France
    • 10.3.7.4. Spain
    • 10.3.7.5. Italy
    • 10.3.7.6. Rest of Europe
• 10.4. South America
  • 10.4.1. Introduction
  • 10.4.2. Key Region-Specific Dynamics
  • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Resolution Type
  • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.4.7.1. Brazil
    • 10.4.7.2. Argentina
    • 10.4.7.3. Rest of South America
• 10.5. Asia-Pacific
  • 10.5.1. Introduction
  • 10.5.2. Key Region-Specific Dynamics
  • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Resolution Type
  • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.5.7.1. China
    • 10.5.7.2. India
    • 10.5.7.3. Japan
    • 10.5.7.4. South Korea
    • 10.5.7.5. Rest of Asia-Pacific
• 10.6. Middle East and Africa
  • 10.6.1. Introduction
  • 10.6.2. Key Region-Specific Dynamics
  • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Resolution Type
  • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

• 11.1. Competitive Scenario
• 11.2. Market Positioning/Share Analysis
• 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

• 12.1. Olympus*
  • 12.1.1. Company Overview
  • 12.1.2. Product Portfolio and Description
  • 12.1.3. Financial Overview
  • 12.1.4. Key Developments
• 12.2. Boston Scientific Corporation
• 12.3. Medtronic
• 12.4. KARL STORZ
• 12.5. Stryker Corporation
• 12.6. Fujifilm Corporation
• 12.7. CONMED Corporation.
• 12.8. Pentax Medical (Hoya Group)
• 12.9. Richard Wolf GmbH.
• 12.10. Smith+Nephew.

LIST NOT EXHAUSTIVE

13. Appendix

• 13.1. About Us and Services
• 13.2. Contact Us